ESC 365 - ISAR-REACT 5 - Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome

ESC Premium Access

ISAR-REACT 5 - Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome

Session: Hot Line Session 2

Topic: Pharmacotherapy

Speaker: Professor S. Schuepke (Munich, DE)

Event: ESC CONGRESS 2019

Presentation

About the speaker

Professor Stefanie Schuepke

German Heart Center, Hospital rechts der Isar at the Technical University of Munich, Munich (Germany)

8 presentations

0 follower

11 more presentations in this session

NZOTACS - The New Zealand Oxygen Therapy in Acute Coronary Syndromes trial

Speaker: Professor R. Stewart (Auckland, NZ)

Discussant review - NZOTACS

Speaker: Doctor R. Hofmann (Stockholm, SE)

Questions from the audience and discussion

CONDI-2/ERIC-PPCI - Effect of remote ischemic conditioning on clinical outcomes in patients with ST- segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Speaker: Professor H. Botker (Aarhus, DK)

Discussant review - CONDI-2/ERIC-PPCI

Speaker: Doctor B. Gersh (Rochester, US)

Access the full session

Hot Line Session 2

Speakers: Professor S. Schuepke, Professor R. Stewart, Doctor R. Hofmann, Professor H. Botker, Doctor B. Gersh

About the event

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Related content

ESC Premium Access

APAF-CRT: AV junction ablation and CRT in patients with permanent atrial fibrillation and narrow QRS

28 August 2021

ESC Premium Access

EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalisations in patients with heart failure with a preserved ejection fraction, with and without diabetes

27 August 2021

This platform is supported by